Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

被引：19
|
作者：
Comella, P [1 ]
机构：
[1] Natl Tumor Inst, Div Med Oncol A, I-80131 Naples, Italy
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 02期
关键词：
D O I：
10.1016/S0093-7754(01)90271-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 10
页数：4
相关论文
共 50 条
  • [21] Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
    Ozkaya, Sevket
    Findik, Serhat
    Uzun, Oguz
    Atici, Atilla Guven
    Erkan, Levent
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2008, 2
  • [22] Sequential combination chemotherapy for advanced non-small cell lung cancer: Paclitaxel and cisplatin followed by vinorelbine and cisplatin
    Kim, H
    Kwon, J
    Jung, J
    Kim, J
    Song, H
    Lee, K
    Zang, D
    Ahn, J
    Lee, J
    Park, Y
    LUNG CANCER, 2005, 49 : S253 - S253
  • [23] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
    Georgoulias, V
    Ardavanis, A
    Tsiafaki, X
    Agelidou, A
    Mixalopoulou, P
    Anagnostopoulou, O
    Ziotopoulos, P
    Toubis, M
    Syrigos, K
    Samaras, N
    Polyzos, A
    Christou, A
    Kakolyris, S
    Kouroussis, C
    Androulakis, N
    Samonis, G
    Chatzidaki, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2937 - 2945
  • [24] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [25] Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: A preliminary report
    Shepherd, FA
    Burkes, R
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    LUNG CANCER, 1996, 14 (01) : 135 - 144
  • [26] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [27] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [28] A randomized phase III trial of tirapazamine (T) in combination with cisplatin (C) and vinorelbine (V) versus cisplatin and vinorelbine in advanced non-small cell lung cancer (NSCLC)
    LeChevalier, T.
    Gatzemeier, U.
    Breton, J. L.
    Cigolari, S.
    Stewart, D.
    Von Pawel, J.
    Firvida, J. L.
    Barcelo, J. R.
    Shen, L.
    Loh, E. Y.
    ANNALS OF ONCOLOGY, 2004, 15 : 165 - 165
  • [29] A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401
    In-Jae Oh
    Kyu-Sik Kim
    Young-Chul Kim
    Hee-Jung Ban
    Yong-Soo Kwon
    Yu-Il Kim
    Sung-Chul Lim
    Woong-Ki Chung
    Taek-Keun Nam
    Joo-Young Song
    Mee-Sun Yoon
    Sung-Ja Ahn
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1247 - 1254
  • [30] Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group
    Comella, P
    Frasci, G
    Panza, N
    Manzione, L
    De Cataldis, G
    Cioffi, R
    Maiorino, L
    Micillo, E
    Lorusso, V
    Di Rienzo, G
    Filippelli, G
    Lamberti, A
    Natale, M
    Bilancia, D
    Nicolella, G
    Di Nota, A
    Comella, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1451 - 1457
12345